Epcore NHL-1 Update: Treatment Effective Before CAR T

A subgroup analysis showed that epcoritamab is effective regardless of CAR T–exposure in patients with R/R LBCL.
Medscape Medical News

source https://www.medscape.com/viewarticle/epcore-nhl-1-update-treatment-effective-before-car-t-2024a1000mm8?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?